Labetalol Dosing for Hypertension
Oral Dosing for Chronic Hypertension Management
For chronic hypertension, start labetalol at 100 mg twice daily and titrate upward in 100 mg increments every 2-3 days based on blood pressure response, with a usual maintenance dose of 200-400 mg twice daily and a maximum of 2400 mg daily. 1
Initial Dosing Strategy
- Begin with 100 mg twice daily, whether used alone or added to a diuretic 1
- Assess standing blood pressure after 2-3 days to guide titration 1
- The full antihypertensive effect occurs within 1-3 hours of each dose, allowing office-based assessment of tolerability 1
Titration Protocol
- Increase by 100 mg twice daily every 2-3 days until blood pressure control is achieved 1
- Most patients achieve adequate control with 200-400 mg twice daily 2, 1
- For severe hypertension, doses may range from 1200-2400 mg daily 1
- If side effects (nausea, dizziness) occur with twice-daily dosing, divide the same total daily dose into three times daily administration 1
- Never exceed 200 mg per titration increment when dosing twice daily 1
Special Population Considerations
- Elderly patients: Start at 100 mg twice daily; most achieve control with 100-200 mg twice daily due to slower drug elimination 1
- Pregnant patients: May require three or four times daily dosing due to accelerated drug metabolism during pregnancy 2
- With diuretic therapy: Lower maintenance doses are typically needed; expect additive antihypertensive effects 1
Intravenous Dosing for Hypertensive Emergencies
For hypertensive emergencies, administer labetalol 10-20 mg IV over 1-2 minutes, repeating or doubling the dose every 10 minutes up to a maximum cumulative dose of 300 mg, or use continuous infusion at 0.4-1.0 mg/kg/hour up to 3 mg/kg/hour. 3
IV Bolus Dosing
- Initial dose: 10-20 mg IV over 1-2 minutes 3, 2
- Repeat or double the dose every 10 minutes as needed 3
- Maximum cumulative bolus dose: 300 mg in standard practice 3, 2
- Alternative dosing: 0.3-1.0 mg/kg (maximum 20 mg) slow IV injection every 10 minutes 2
Continuous Infusion Protocol
- Initial rate: 0.4-1.0 mg/kg/hour (approximately 30-80 mg/hour for a 70-80 kg adult) 3
- Maximum rate: 3 mg/kg/hour (approximately 200-240 mg/hour for a 70 kg patient) 3
- Alternative starting rate: 2 mg/min (2 mL/min), titrated to blood pressure response 3
Practical Infusion Dosing Ranges
- Low-dose: 30-50 mg/hour (0.4-0.7 mg/kg/hour for 70 kg patient) 3
- Moderate-dose: 70-120 mg/hour (1.0-1.7 mg/kg/hour for 70 kg patient) 3
- High-dose: 150-210 mg/hour (2.1-3.0 mg/kg/hour for 70 kg patient) 3
Clinical Scenario-Specific Dosing
Acute Ischemic Stroke
- Thrombolytic-eligible patients (BP >185/110 mmHg): Give 10-20 mg IV over 1-2 minutes; may repeat once, then maintain BP <185/110 mmHg 3, 2
- Non-thrombolytic patients (systolic >220 mmHg or diastolic 121-140 mmHg): Give 10-20 mg IV over 1-2 minutes, targeting 10-15% BP reduction 3, 2
Acute Hemorrhagic Stroke
- Target systolic BP <180 mmHg using labetalol infusion 3
- Use infusion rates of 0.4-1.0 mg/kg/hour up to 3 mg/kg/hour 3
Severe Preeclampsia/Eclampsia
- Initial dose: 20 mg IV bolus, then 40 mg after 10 minutes, then 80 mg every 10 minutes for 2 additional doses (maximum 220 mg) 2
- Alternative: Continuous infusion at 0.4-1.0 mg/kg/hour up to 3 mg/kg/hour 3
- Target: Systolic BP <160 mmHg and diastolic BP <105 mmHg 3
- Maximum cumulative dose: 800 mg/24 hours to prevent fetal bradycardia 3
Acute Aortic Dissection
- Target systolic BP ≤120 mmHg and heart rate ≤60 bpm 3
- Use labetalol as first-line therapy with ultra-short acting vasodilators 3
Malignant Hypertension/Hypertensive Encephalopathy
- Goal: Reduce mean arterial pressure by 20-25% over several hours 3
- Use continuous infusion at 0.4-1.0 mg/kg/hour up to 3 mg/kg/hour 3
Blood Pressure Targets and Monitoring
Target Blood Pressure Reductions
- General hypertensive emergencies: Reduce mean arterial pressure by 20-25% over several hours 3
- Acute ischemic stroke: 10-15% reduction 3, 2
- Acute hemorrhagic stroke: Systolic BP <180 mmHg 3
- Thrombolytic-eligible stroke: Maintain BP <185/110 mmHg 3, 2
Monitoring Frequency
- First 2 hours: Every 15 minutes 3
- Next 6 hours: Every 30 minutes 3
- Subsequent 16 hours: Every hour 3
- For acute hemorrhagic stroke: Every 15 minutes until stabilized for first 24-48 hours 3
Absolute Contraindications
Do not use labetalol in patients with the following conditions, regardless of dose: 3, 2
- Second- or third-degree heart block 3, 2
- Bradycardia 3, 2
- Decompensated heart failure 3, 2
- Reactive airways disease (asthma) 3, 2
- Chronic obstructive pulmonary disease (COPD) 3, 2
Critical Safety Considerations
Common Pitfalls
- Avoid rapid or excessive BP falls: Target gradual reduction over several hours, not minutes 3
- Do not exceed 300 mg cumulative bolus dose without switching to infusion in standard practice 3, 2
- Monitor for profound cardiovascular compromise with prolonged infusions, particularly in critically ill patients 4
- Have reversal agents readily available: Glucagon, beta-agonists, phosphodiesterase inhibitors, insulin, and vasopressin should be accessible when using continuous infusions 4
Common Adverse Effects
- Hypotension, bradycardia, nausea, scalp tingling, and burning sensations 3
- Fluid retention (easily controlled with diuretics) 5
- Postural hypotension, particularly with initial dosing 5